Principal Financial Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $826K | Sell |
13,067
-24,089
| -65% | -$1.52M | ﹤0.01% | 1919 |
|
|
2025
Q1 | $1.97M | Buy |
37,156
+272
| +0.7% | +$14.4K | ﹤0.01% | 1773 |
|
|
2024
Q4 | $2.06M | Buy |
36,884
+4,298
| +13% | +$241K | ﹤0.01% | 1793 |
|
|
2024
Q3 | $1.71M | Buy |
32,586
+23,054
| +242% | +$1.21M | ﹤0.01% | 1789 |
|
|
2024
Q2 | $391K | Buy |
9,532
+2,352
| +33% | +$96.6K | ﹤0.01% | 2009 |
|
|
2024
Q1 | $311K | Buy |
7,180
+1,227
| +21% | +$53.2K | ﹤0.01% | 2079 |
|
|
2023
Q4 | $274K | Buy |
+5,953
| New | +$274K | ﹤0.01% | 2087 |
|
|
2021
Q3 | – | Sell |
-11,364
| Closed | -$223K | – | 2615 |
|
|
2021
Q2 | $223K | Buy |
11,364
+1,562
| +16% | +$30.7K | ﹤0.01% | 2444 |
|
|
2021
Q1 | $208K | Sell |
9,802
-8,000
| -45% | -$170K | ﹤0.01% | 2375 |
|
|
2020
Q4 | $529K | Buy |
+17,802
| New | +$529K | ﹤0.01% | 2097 |
|
|
2020
Q3 | – | Sell |
-9,377
| Closed | -$209K | – | 2351 |
|
|
2020
Q2 | $209K | Buy |
+9,377
| New | +$209K | ﹤0.01% | 2179 |
|